CHMP issues positive opinion for use of Plavix with aspirin in adults within 24 hours of minor ischemic stroke or high-risk transient ischemic attack Positive opinion based on clinical data ...
The researchers found that the primary outcome was experienced by 17.6% of patients prescribed Plavix and 17.9% prescribed clopidogrel at 1 year (hazard ratio, 1.02; 95% confidence interval, 0.96 to 1 ...
pill bottles The Food and Drug Administration (FDA) has approved several changes to the prescribing information for Plavix (clopidogrel bisulfate tablets; Bristol-Myers Squibb and Sanofi). The Food ...
Rockville, MD - The FDA has now approved clopidogrel (Plavix® - Sanofi-Synthelabo/Bristol-Myers Squibb) for acute coronary syndromes (ACS), expanding its indication ...
Jacksonville, FL - Data from a pharmacodynamic study suggests that acute coronary syndrome (ACS) patients can be safely switched from maintenance clopidogrel (Plavix, Bristol-Myers ...
MIAMI, Oct. 23, 2012 /PRNewswire/ -- Daiichi Sankyo, Inc. and Eli Lilly and Company (NYSE: LLY) today announced new results of two retrospective, observational, comparative effectiveness studies of ...
New sublingual delivery system designed to enhance bioavailability and avoid gastric side effects many patients experience with clopidogrel. Clopidogrel, currently sold under the brand name Plavix® ...
Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...
Canadian generic drug firm Apotex appears to have outwitted pharma giant Bristol-Myers Squibb (BMS) and marketing partner Sanofi-Aventis in negotiations over the blood thinner Plavix. Thanks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results